4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-035121
Chief Financial Officer bought 39,062 shares at an average $1.74 ($68,123)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2023-06-05 | Purchase | +20,000 | $1.67 | $33,344 | 480,188 | D |
| Byam Rebecca Chief Financial Officer | 2023-06-06 | Purchase | +19,062 | $1.82 | $34,779 | 499,250 | D |
| Open-market purchases · 39,062 sh · avg $1.74 · $68,123 | |||||||
Loading xslF345X04/doc4.xml…